Clinical trial · Interventional
FDG PET-MRI for the Diagnosis of Spinal Cord Lesions
Ideal Imaging Time Point Assessment for Spinal Cord Lesions of Unknown Etiology With FDG PET-MRI
NCT04219969CI-TRIAL-00076994completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To compare the results and understand the possible benefits from FDG-PET/MRI during different scanning time points after FDG, a type of contrast drug, is given.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Spinal Cord Neoplasm | Spinal Cord Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Fludeoxyglucose F-18 | Drug | — | UNRESOLVED |
| Magnetic Resonance Imaging | Device | — | UNRESOLVED |
| Positron Emission Tomography | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Diagnostic (18F-FDG PET-MRI)
- description
- Patients receive fludeoxyglucose F-18 IV over 1 minutes and then undergo PET-MRI over 15-60 minutes at 60, 300, and 480 minutes after fludeoxyglucose F-18 injection in the absence of unacceptable toxicity.
- interventionNames
- Drug: Fludeoxyglucose F-18
- Device: Magnetic Resonance Imaging
- Procedure: Positron Emission Tomography
Primary outcomes (3)
- measure
- Standard uptake value (SUV) max
- timeFrame
- Up to 8 hours
- description
- Identifying the specific malignancy
- measure
- Lesion to background (L/B) ratio
- timeFrame
- Up to 8 hours
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with untreated intramedullary cord lesion(s) * Ability to undergo FDG PET MR examination Exclusion Criteria: * No prior surgery or biopsy of the spinal cord * No metal implanted in area of interest * Spine radiation therapy * Known allergy to FDG or gadolinium based contrast agents * Blood glucose (\> 200 mg/dl) * Pregnant women are excluded * Children of less than 18 years of age * Need for conscious sedation or anesthesia in order to tolerate study
References
Publications (0)
Data not yet available
No reference posted for this study.